Despite concerns about ultra-processed foods (UPFs) and non-communicable diseases (NCDs), evidence of causality remains unclear; reformulating UPFs may offer significant health advantages.
Gilead’s PBC therapy Livdelzi bags accelerated approval – Pharmaceutical Technology
Livdelzi could offer life-saving treatment to PBC patients where no cures or effective therapies are available. Image: GettyImages/ Sebastian Kaulitzki Gilead Sciences’ Livdelzi (seladelpar) has